These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 36975168

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Jabbari E, Holland N, Chelban V, Jones PS, Lamb R, Rawlinson C, Guo T, Costantini AA, Tan MMX, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, Holton JL, Revesz T, Warner TT, Lees AJ, Zetterberg H, Russell LL, Bocchetta M, Rohrer JD, Williams NM, Grosset DG, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu MTM, Woodside J, Houlden H, Rowe JB, Morris HR.
    JAMA Neurol; 2020 Mar 01; 77(3):377-387. PubMed ID: 31860007
    [Abstract] [Full Text] [Related]

  • 3. Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes.
    Gilman S, Koeppe RA, Nan B, Wang CN, Wang X, Junck L, Chervin RD, Consens F, Bhaumik A.
    Neurology; 2010 May 04; 74(18):1416-23. PubMed ID: 20439843
    [Abstract] [Full Text] [Related]

  • 4. The utility of FDG-PET in the differential diagnosis of Parkinsonism.
    Brajkovic L, Kostic V, Sobic-Saranovic D, Stefanova E, Jecmenica-Lukic M, Jesic A, Stojiljkovic M, Odalovic S, Gallivanone F, Castiglioni I, Radovic B, Trajkovic G, Artiko V.
    Neurol Res; 2017 Aug 04; 39(8):675-684. PubMed ID: 28378615
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Magnetic Susceptibility in Progressive Supranuclear Palsy Variants, Parkinson's Disease, and Corticobasal Syndrome.
    Satoh R, Weigand SD, Pham NTT, Ali F, Arani A, Senjem ML, Jack CR, Whitwell JL, Josephs KA.
    Mov Disord; 2023 Dec 04; 38(12):2282-2290. PubMed ID: 37772771
    [Abstract] [Full Text] [Related]

  • 10. Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy.
    Constantinides VC, Paraskevas GP, Stamboulis E, Kapaki E.
    Neurol Sci; 2018 Feb 04; 39(2):359-364. PubMed ID: 29196955
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM, Srulijes K, Gröger A, Maetzler W, Berg D.
    Acta Neurol Scand; 2013 May 04; 127(5):362-70. PubMed ID: 23406296
    [Abstract] [Full Text] [Related]

  • 14. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL, Tosakulwong N, Botha H, Ali F, Clark HM, Duffy JR, Utianski RL, Stevens CA, Weigand SD, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Ahlskog JE, Dickson DW, Josephs KA.
    Neuroimage Clin; 2020 May 04; 25():102152. PubMed ID: 31935638
    [Abstract] [Full Text] [Related]

  • 15. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K, Imabayashi E, Tokumaru AM, Ito K, Shimoji K, Nakagawa M, Ozawa Y, Shimohira M, Ogawa M, Morimoto S, Aiba I, Matsukawa N, Shibamoto Y.
    Magn Reson Med Sci; 2017 Jan 10; 16(1):16-22. PubMed ID: 27001391
    [Abstract] [Full Text] [Related]

  • 16. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
    Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC.
    Mov Disord; 2006 Jul 10; 21(7):989-96. PubMed ID: 16602104
    [Abstract] [Full Text] [Related]

  • 17. Thalamic and cerebellar hypoperfusion in single photon emission computed tomography may differentiate multiple system atrophy and progressive supranuclear palsy.
    Alster P, Nieciecki M, Koziorowski DM, Cacko A, Charzyńska I, Królicki L, Friedman A.
    Medicine (Baltimore); 2019 Jul 10; 98(30):e16603. PubMed ID: 31348305
    [Abstract] [Full Text] [Related]

  • 18. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M.
    J Neurol; 2018 Nov 10; 265(11):2602-2613. PubMed ID: 30178175
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration.
    Illán-Gala I, Nigro S, VandeVrede L, Falgàs N, Heuer HW, Painous C, Compta Y, Martí MJ, Montal V, Pagonabarraga J, Kulisevsky J, Lleó A, Fortea J, Logroscino G, Quattrone A, Quattrone A, Perry DC, Gorno-Tempini ML, Rosen HJ, Grinberg LT, Spina S, La Joie R, Rabinovici GD, Miller BL, Rojas JC, Seeley WW, Boxer AL.
    JAMA Netw Open; 2022 Apr 01; 5(4):e229588. PubMed ID: 35486397
    [Abstract] [Full Text] [Related]

  • 20. Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study.
    Quattrone A, Morelli M, Quattrone A, Vescio B, Nigro S, Arabia G, Nisticò R, Novellino F, Salsone M, Arcuri P, Luca A, Mazzuca A, Alessio C, Rocca F, Caracciolo M.
    Parkinsonism Relat Disord; 2020 Mar 01; 72():1-6. PubMed ID: 32036297
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.